Hello, I am Meriem Bouslouk-Marx

When Germany introduced AMNOG – the legislation on the benefit assessment of medicinal products – in 2011, I joined the initial small team at the Federal Joint Committee G‑BA in charge of implementing the procedure. In this position, I prepared binding national decisions published in the Federal Gazette. My main responsibilities included conducting Scientific Consultations with pharmaceutical companies and involved Regulatory Authorities on clinical trial design. In addition, I assessed dossiers to prepare G‑BA Resolutions.

My particular focus from the outset was on the benefit assessment of new orphan drugs. At the G-BA, I co-ordinated the specific health policy procedure for their assessment in Germany.

From the start in 2011, I was entrusted to promote the G-BA’s work outside Germany: In lectures and speeches – within and outside the G‑BA – I fostered partnerships with European and international organisations. Until today, national and international relationships are an asset. Besides German, I speak French, Arabic and English as well as basic Spanish.

After my French Baccalauréat at Lycée Descartes in Rabat, Morocco, I graduated with a PhD in Dental Medicine from the Friedrich Schiller University in Jena, Germany and hold a postgraduate Master of Science in International Health from the Charité – Universitätsmedizin Berlin.  At the beginning of my career, I worked with Public Health projects in Africa, also in dental offices in Berlin.